Home/Filings/4/0001225208-17-004737
4//SEC Filing

BOSTON SCIENTIFIC CORP 4

Accession 0001225208-17-004737

$BSXCIK 0000885725operating

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:28 PM ET

Size

8.0 KB

Accession

0001225208-17-004737

Insider Transaction Report

Form 4
Period: 2017-02-24
Dawkins Keith D
Sr. VP, Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-24+2,29380,086 total
  • Tax Payment

    Common Stock

    2017-02-24$24.78/sh867$21,48479,219 total
  • Exercise/Conversion

    Deferred Stock Units

    2017-02-242,2934,588 total
    Exp: 2019-02-24Common Stock (2,293 underlying)
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000885725

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:28 PM ET
Size
8.0 KB